Endoscopic Submucosal Dissection for Gastric Epithelial Tumors: A Multicenter Study in Taiwan

Abstract

ESD is a promising local curative treatment option for EGC in Taiwan but it still carries risks of perforation and bleeding. The education and learning curve of endoscopists will improve the outcome of this procedure.

Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications

“…11,12 However, our overall perforation rate was lower than that in previous studies, 11,12,15,18,[20][21][22] because we included absolute indication and EMR cases. Procedure time was longer for tumors with submucosal fibrosis (P Ͻ .001), for larger tumors (P Ͻ .001), and for the ESD procedure (P ϭ .005); all of these factors were predominant in the extended indication group.…”

Proton Pump Inhibitors versus Histamine-2-Receptor Antagonists for the Management of Iatrogenic Gastric Ulcer after Endoscopic Mucosal Resection or Endoscopic Submucosal Dissection: A Meta-Analysis of Randomized Trials

“…Although they are not very popular in Western countries due to many concerns and limited expertise [2], EMR and ESD have become standard therapies for early gastric cancer in Japan [3], South Korea [4] and China [5]. However, a large artificial gastric ulcer induced by endoscopic therapies causes many complications including pain, bleeding and perforation [6].…”

Hospital Authority audit of the outcome of endoscopic resection of superficial upper gastro-intestinal lesions in Hong Kong

“…The adoption of ESD outside Japan and Korea has been slow. 5,8,[15][16][17][18] The reported studies were mostly small series and the results were variable. In four European and two South-East Asian studies, the number of patients included was between 23 and 70, the en-bloc resection rate ranged from 25% to 100% and morbidity 0% to 24%.…”